Drugs / DNAmix
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06361264 | Nov 2018 → Dec 2024 | female breast carcinoma | KARANAHAN | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DNAmix | “The schedule of administering cyclophosphamide and DNAmix complex composite preparation is calculated according to the resulting time points.” NCT06361264 ↗ |
| Route | Other | “4 injections of 1-12 mg of DNAmix administered into prominent tumor nidi and lymph depots” NCT06361264 ↗ |